Paternal Longevity Indicator and Your Genetics
Paternal Longevity Genetics: SORT1, LDLR, and IGF2R | ExomeDNA
By the ExomeDNA Research Team | Last reviewed May 2026
Research base: Moderate.
What is paternal longevity as a genetic trait?
Paternal longevity, as studied in genome-wide analyses, uses a parent's age at death or attained age as a proxy phenotype for genetic influences on lifespan. Because an individual's longevity unfolds over decades, analyzing the age of a parent serves as an informative alternative—a person whose father lived to older ages may carry genetic variants that supported that longevity, and those variants may also be relevant to the offspring's own genetic architecture. This proxy approach has enabled genome-wide studies with the statistical power needed to identify replicating genetic signals.
Favorable genetic scores in this analysis are associated with longer-lived fathers in the study population. The gene set identified in paternal longevity is dominated by cardiovascular lipid metabolism genes, consistent with the well-established pattern that men's mortality in mid-to-late life is disproportionately shaped by cardiovascular disease.
The genetics behind paternal longevity
The strongest genetic associations with paternal longevity include variants near SORT1, CELSR2, LDLR, LPL, IGF2R, PSRC1, APOE, and SH2B3. The gene set closely resembles the genetic architecture of LDL cholesterol and cardiovascular risk—pointing to lipoprotein metabolism as the primary mediator of heritable differences in father's lifespan.
SORT1, CELSR2, and PSRC1 all map to the 1p13 chromosomal locus, one of the most robustly replicated genetic loci for LDL cholesterol. PSRC1 (proline-serine-rich coiled-coil protein 1) regulates SORT1 expression and both work in concert to control hepatic VLDL secretion and LDL production. LDLR encodes the LDL receptor that clears LDL particles from circulation; variants that reduce LDLR activity increase LDL levels and cardiovascular risk. LPL (lipoprotein lipase) releases fatty acids from triglyceride-rich VLDL for tissue uptake, and its genetic variation influences triglyceride levels and associated cardiovascular risk.
A prospective genetic analysis of parental lifespan identified variants at the 1p13 LDL locus (SORT1, CELSR2, PSRC1), LDL receptor, and IGF2R as significantly associated with father's age at death, consistent with cardiovascular risk genetics driving heritable variance in male longevity (Wright et al., 2019).
IGF2R encodes the insulin-like growth factor 2 receptor, also known as the cation-independent mannose-6-phosphate (CI-MPR) receptor. IGF2R binds IGF-2 and targets it for lysosomal degradation, acting as a negative regulator of IGF-2 bioavailability. In model organisms from nematodes to mice, reduced insulin/IGF-1 signaling is among the most robust experimental interventions for extending lifespan. The IGF2R association in paternal longevity represents a potential human signal for the growth factor-longevity axis—where attenuated IGF-2 activity, mediated by more active IGF2R clearance, is associated with longer paternal lifespan.
APOE is a well-established longevity gene across multiple analyses. The ε2 allele is associated with favorable cardiometabolic profiles and longer lifespan, while the ε4 allele increases cardiovascular and neurodegenerative disease susceptibility. SH2B3 (also called LNK) is a hematopoietic adaptor protein that regulates stem cell proliferation and platelet production. Variants in SH2B3 associate with blood cell counts and inflammatory markers; its role in paternal longevity may reflect an immune or hematologic component of male aging trajectories. CLU encodes clusterin, a molecular chaperone associated with protein aggregation and neurodegeneration, with a broader role in cellular stress responses relevant to aging biology.
What the research says
Wright et al. (2019) conducted a prospective genome-wide analysis of genetic variants associated with parental lifespan, using cohort data where participants reported parents' ages at death or current ages. Analyzing paternal and maternal longevity separately revealed distinct genetic architectures—paternal longevity signals cluster in cardiovascular lipid metabolism pathways, while maternal longevity signals have a different composition. This sex-differential pattern aligns with epidemiological patterns of mortality: men's mid-life mortality is disproportionately cardiovascular, while women's longevity landscape incorporates additional factors including smoking behavior and neurodegenerative disease trajectories.
The use of parental age as a proxy phenotype increases statistical power substantially but comes with limitations. The genetic signal reflects variants that influenced parents' lifespans in a specific historical context, diet, and healthcare environment, which may not translate directly to future generations. Nonetheless, the genetic signals identified—particularly the cardiovascular loci—are biologically well-grounded and replicate across multiple independent longevity analyses.
Paternal longevity genetics is dominated by the same LDL metabolism gene set (1p13 locus, LDLR, LPL) that predicts cardiovascular disease risk across independent GWAS, suggesting that heritable male lifespan is significantly shaped by inherited lipid metabolism efficiency (Wright et al., 2019).
How paternal longevity genetics affects you
The genetic variants in this analysis are associated with more favorable cardiovascular lipid profiles—lower LDL, better lipoprotein metabolism—and with attenuated IGF-2 signaling. These biological pathways do not produce direct health effects in isolation; they shape individual susceptibility within the larger context of lifestyle, diet, medical care, and environment. Understanding the biological architecture underlying paternal longevity provides context for prioritizing relevant health domains rather than determining any specific outcome.
The prominence of lipid metabolism genes in paternal longevity underscores why cardiovascular health interventions—diet, exercise, lipid management—have historically strong associations with extending healthy lifespan in men. Genetic predispositions in this analysis operate through the same biological systems that lifestyle choices and medical interventions modulate.
Working with your profile
The cardiovascular pathways implicated in paternal longevity are among the most modifiable by lifestyle. Regular aerobic exercise improves LDL particle quality and increases HDL, directly affecting the lipoprotein biology encoded by SORT1, LDLR, and LPL. Mediterranean-style dietary patterns are associated with favorable LDL profiles and lower cardiovascular event rates. Avoiding tobacco, managing blood pressure, and maintaining healthy body weight all address modifiable contributors to cardiovascular aging.
For the IGF-2 signaling angle, caloric restriction and time-restricted eating have been associated with reduced IGF-1/IGF-2 pathway activity in multiple studies. Exercise itself modulates IGF signaling in complex ways that may relate to longevity pathways studied in model organisms. These connections remain an active research area.
This content is provided for educational purposes only.
Related traits and genes
Paternal longevity genetics overlaps substantially with LDL cholesterol, coronary artery disease risk, and total cardiovascular risk traits. SORT1, CELSR2, PSRC1, and LDLR are all replicated LDL genetics signals. APOE appears across multiple longevity, cardiovascular, and neurodegeneration phenotypes. IGF2R is more distinctive to growth factor regulation and longevity biology. Maternal longevity shares APOE but diverges substantially in its other top signals, reflecting sex-differential pathways in aging biology.